Mergers & AcquisitionsBy The Online Investor Staff, updated Fri., Feb. 3, 12:10 PM
|This Slide: #42 of 100|
Slide #42. Irwin Naturals Inc. — Braxia Scientific Corp.
Irwin Naturals Inc. (IWINF)
Braxia Scientific Corp.
Irwin Naturals Inc. (CSE: IWIN) (OTC: IWINF) (FRA: 97X) ("Irwin" or the "Company"), is pleased to announce it has entered into a non-binding amended and restated Letter of Intent ("LOI") for a business combination with Braxia Scientific Corp. ("Braxia Scientific"), (CSE: BRAX) (OTC: BRAXF) (FWB: 4960), a medical research company providing psychiatric, innovative ketamine and psilocybin treatments for mental health disorders. The LOI sets forth the material terms and conditions upon which Irwin will acquire all of the issued and outstanding common shares (the "Braxia Shares") of Braxia (the "Proposed Transaction").